Leishmaniasis: Epidemiological Report of the Americas, No. 10. December 2021

This report presents a detailed analysis of cutaneous, mucosal, and visceral leishmaniasis data in the Region of the Americas for 2020 and includes a series of infographics with specific data on cutaneous and mucosal leishmaniasis in endemic countries. As a result of the COVID-19 pandemic, active search activities, early detection and treatment of cases, as well as other field activities, have been reduced. Among the challenges facing the Region, we highlight the need for countries to resume activities and move forward with the diagnosis and treatment of cases of the different clinical forms of the disease. Furthermore, it is necessary to identify strategies for the follow-up and monitoring of cases, in order to achieve the targets of treating at least 90% of patients diagnosed with cutaneous and mucosal leishmaniasis, as well as reducing the lethality of visceral leishmaniasis to less than 50% in the Region.